BB Biotech AG
BBAGF
Updated: 24/09/2026, 10:36:34
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.
No summaries found.
- Share price
- $64.36
- Market cap
- $4.94B
- Exchange
- OTC
- Currency
- USD
- CEO
- Daniel Koller
- Employees
- 10
- IPO date
- 12/10/2015
- Beta
- 0.576
- Last dividend
- $0.00
- Day range
- $64.36 – $64.36
- 52-week range
- $33.65 – $76.06
- 1-day performance
- 5.20%
- 1-year performance
- 91.29%
- Current drawdown (1Y)
- -15.38%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- CH0038389992
- Created
- 07/12/2025, 02:55:36
- Last update
- 24/09/2026, 10:36:34
Track BB Biotech AG with an AI analyst
See which prediction-market events move BBAGF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.